N-Ethyl-4-Formyl-Benzeneacetamide: Key Intermediate for Elacestrant Synthesis
Unlock advancements in cancer therapy with our high-quality Elacestrant intermediate for research and development.
Get a Quote & SampleProduct Core Value
N-Ethyl-4-Formyl-Benzeneacetamide
This N-Ethyl-4-Formyl-Benzeneacetamide is a critical pharmaceutical intermediate, essential for the synthesis of Elacestrant, a groundbreaking treatment for advanced ER+/HER2- metastatic breast cancer. Its precise chemical structure and high purity ensure efficacy in drug development.
- Leveraging N-Ethyl-4-Formyl-Benzeneacetamide synthesis, researchers can develop next-generation cancer therapies.
- As a key CAS 2477812-42-1 chemical, its reliable supply is vital for pharmaceutical production.
- Procure this essential buy Elacestrant precursor to advance your oncology research and development pipelines.
- We are a trusted pharmaceutical intermediate supplier, committed to quality and consistency for your critical projects.
Key Advantages
Certified Quality
Benefit from a product certified with GMP, ISO 9001, and FDA standards, ensuring the highest quality for pharmaceutical applications.
Research Advancement
Utilize this critical chemical synthesis intermediate to accelerate your cancer research and drug discovery efforts.
Reliable Supply Chain
Depend on our robust supply chain for consistent availability of this essential Elacestrant intermediate, supporting your ongoing projects.
Key Applications
API Manufacturing
Essential for the production of Active Pharmaceutical Ingredients (APIs) like Elacestrant, supporting large-scale pharmaceutical manufacturing.
Oncology Drug Development
Crucial for the development of targeted therapies, particularly for breast cancer treatment, utilizing the unique properties of this intermediate.
Chemical Synthesis Research
A valuable compound for academic and industrial research in advanced chemical synthesis and organic chemistry.
Custom Synthesis Projects
Serves as a foundational element for custom synthesis projects requiring specific chemical structures for novel applications.